Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibitors of HIV-1 reverse transcriptase.

× No keyword cloud information.

24 in total

Review 1. Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.

Authors: Nicolas Sluis-Cremer; N Alpay Temiz; Ivet Bahar
Journal: Curr HIV Res Date: 2004-10 Impact factor: 1.581

2. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.

Authors: Matthew M Schuckmann; Bruno Marchand; Atsuko Hachiya; Eiichi N Kodama; Karen A Kirby; Kamalendra Singh; Stefan G Sarafianos
Journal: J Biol Chem Date: 2010-09-27 Impact factor: 5.157

3. Stereo-selectivity of HIV-1 reverse transcriptase toward isomers of thymidine-5'-O-1-thiotriphosphate.

Authors: Jessica Radzio; Nicolas Sluis-Cremer
Journal: Protein Sci Date: 2005-06-03 Impact factor: 6.725

4. Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.

Authors: Qing Xia; Jessica Radzio; Karen S Anderson; Nicolas Sluis-Cremer
Journal: Protein Sci Date: 2007-08 Impact factor: 6.725

5. Efavirenz stimulates HIV-1 reverse transcriptase RNase H activity by a mechanism involving increased substrate binding and secondary cleavage activity.

Authors: John M Muchiri; Dongge Li; Carrie Dykes; Robert A Bambara
Journal: Biochemistry Date: 2013-07-09 Impact factor: 3.162

6. The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.

Authors: K A Kirby; K Singh; E Michailidis; B Marchand; E N Kodama; N Ashida; H Mitsuya; M A Parniak; S G Sarafianos
Journal: Cell Mol Biol (Noisy-le-grand) Date: 2011-02-12 Impact factor: 1.770

7. Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism.

Authors: Lindsay J Yanakakis; Namandjé N Bumpus
Journal: Drug Metab Dispos Date: 2012-01-23 Impact factor: 3.922

8. Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors.

Authors: Valentina Svicher; Tobias Sing; Maria Mercedes Santoro; Federica Forbici; Fátima Rodríguez-Barrios; Ada Bertoli; Niko Beerenwinkel; Maria Concetta Bellocchi; Federigo Gago; Antonella d'Arminio Monforte; Andrea Antinori; Thomas Lengauer; Francesca Ceccherini-Silberstein; Carlo Federico Perno
Journal: J Virol Date: 2006-07 Impact factor: 5.103

9. Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor.

Authors: Eleftherios Michailidis; Bruno Marchand; Eiichi N Kodama; Kamlendra Singh; Masao Matsuoka; Karen A Kirby; Emily M Ryan; Ali M Sawani; Eva Nagy; Noriyuki Ashida; Hiroaki Mitsuya; Michael A Parniak; Stefan G Sarafianos
Journal: J Biol Chem Date: 2009-12-18 Impact factor: 5.157

10. Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.

Authors: Kamalendra Singh; Bruno Marchand; Karen A Kirby; Eleftherios Michailidis; Stefan G Sarafianos
Journal: Viruses Date: 2010-02-11 Impact factor: 5.048